An interview with
Dr. Jean-Pierre Frat

Nasal High Flow (NHF) - Clinical research and clinical practice


Dr. Jean-Pierre Frat, chief investigator of the landmark FLORALI study, talks to us about his experience as a researcher and clinician, reflecting on a decade of using NHF. We discuss the practical application of NHF for multiple applications in Acute Hypoxemic Respiratory Failure.
An Interview with Jean-Pierre Frat

Watch the full interview now (22 mins)


or
 

Watch in bite-sized pieces (scroll down)

or

Listen to the audio file     audio icon

The interview in bite-sized pieces

Dr Jean-Pierre Frat NHF Settings
What NHF settings do you start with and why?


(2 min 34 sec)
 
Dr Jean-Pierre Frat Patient Escalation
How do you monitor patients and make the decision to escalate?


(6 min 09 sec)
 
Dr Jean-Pierre Frat Approach to Weaning off NHF
What's your approach to weaning patients from NHF?


(1 min 44 sec)
Dr. Jean Frat - NHF in supporting intubation
The role of NHF in supporting intubation

(2 min 59 sec)
 
Dr. Jean Frat - NHF for post-extubation support
NHF for post-extubation support

(4 min 37 sec)
 
Dr Jean-Pierre Frat 60 Centre Study
What next? Dr. Frat talks about a new 60-center study hoping to recruit 1,100 patients.

(1 min 52 sec)
 

Dr. Jean-Pierre Frat (MD, PhD) is currently working in the medical ICU at the University Hospital of Poitiers in France. He works within the ALIVE lab working on non-invasive strategies of oxygenation and sleep disorders in ICU patients. He has conducted several multicentre clinical trials in collaboration with the European network REVA assessing the impact of non-invasive respiratory therapies including the landmark FLORALI study. Currently, he is conducting another important clinical trial, the SOHO study which will assess conventional oxygen therapy and NHF in patients with acute hypoxemic respiratory failure.

Key clinical studies

These are some of the studies referenced by Dr. Frat during the interview

Frat et al. 2015. NEJM. aka the FLORALI study

Download PDF

Further reading:
Pubmed abstract
Thille et al. 2019. JAMA. aka the HIGH-WEAN study

Download PDF

Further reading:
Pubmed abstract


App new icon

F&P ROX Index Calculator app

Using just 3 data points (SpO2, respiratory rate and FiO2) the validated ROX index* provides an indicator of Nasal High Flow outcomes in adults experiencing acute hypoxemic respiratory failure due to pneumonia. Download the app to learn more about and practice using this index.
 
App Store Download Play Store Download
*Roca et al. Am J Respir Crit Care Med. 2019.
 
    
ROX app
If you have an enquiry about our products, please provide the following information so a Fisher & Paykel Healthcare representative can contact you. For further details on how this information will be used, see below or go to our privacy statement.
Contact Details
Please select from the following options:*

Enter security code
 Security code
By submitting this form, you consent to Fisher & Paykel Healthcare storing your personal information to contact you about your enquiry. Your information will be collected and stored securely by Fisher & Paykel Healthcare Limited based in New Zealand and may be shared with the wider Fisher & Paykel Healthcare group as necessary to support your enquiry. We will not share, disclose or sell your information to third parties for marketing purposes. For full details on how we use and manage your personal information, how long we may retain this information for sales or marketing purposes, your rights to access, correct or delete your personal information, and how to contact us about your personal information, please see our privacy statement.

Want to receive updates?

Sign up to receive email notifications of the latest product and therapy information as well as upcoming events.
 

Sign up here